'Cancer will be history in 10 years': Anthropic CEO's big AI-powered promise
Times of India
Anthropic is engaging in partnerships with various biotechnology firms to
enhance the pace of drug discovery. These collaborations aim to create
solutions for cancer, food allergies, and rare diseases, showcasing notable
advancements in T-cell therapies and antibody designs. Furthermore, Anthropic
is investigating its own drug innovations targeting muscular dystrophy, though
much of the research is still in preclinical phases prior to clinical trials.


